Nicotine Psychopharmacology pp 369-400

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 192)

Discriminative Stimulus Effects of Nicotine in Humans

  • Kenneth A. Perkins

Abstract

Behavioral discrimination procedures clearly demonstrate that nicotine elicits interoceptive stimulus effects in humans that are malleable by various pharmacological manipulations as well as by some behavioral manipulations. The parameters of nicotine discrimination and both chronic and acute factors that may alter discrimination behavior are addressed in this chapter, which emphasizes research by the author involving nicotine delivered by nasal spray. Human discrimination of nicotine is centrally mediated, as the central and peripheral nicotine antagonist mecamylamine blocks discrimination but the peripheral antagonist trimethaphan does not. The threshold dose for discrimination of nicotine via spray appears to be very low in smokers as well as nonsmokers. Because smoked tobacco delivers nicotine more rapidly than spray, the threshold dose of nicotine via smoking is probably even lower. In terms of individual differences, smokers may become tolerant to the discriminative stimulus effects of higher nicotine doses but not of low doses. Men may be more sensitive than women to nicotine's discriminative stimulus effects, consistent with other research suggesting that nicotine is more reinforcing in men than in women. Other potential individual differences in nicotine discrimination have not been clearly tested, but may include genetics, obesity, and dependence on other drugs. Acute environmental factors that alter nicotine discrimination include the specific training and testing conditions, pointing to the need for careful control over such conditions during research. Other factors, such as concurrent acute use of alcohol or caffeine, do not appear to alter nicotine discrimination, suggesting that changes in nicotine discrimination are not likely explanations for the association of smoking behavior with use of those drugs. Concurrent physical activity also does not appear to alter nicotine discrimination, indicating that results from studies of discrimination in subjects at quiet rest, the standard approach in this research, generalize well to discrimination in subjects engaged in various activities, as often occurs in the natural environment. Future research should more clearly examine the potential role of nicotine's discriminative stimulus effects in nicotine reinforcement and determine the generalizability of these findings to nicotine delivered by other means, particularly tobacco smoking.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abreu ME, Griffiths RR (1996) Drug tasting may confound human drug discrimination studies. Psychopharmacology 125:255–257PubMedCrossRefGoogle Scholar
  2. Audrain-McGovern J, Nigg J, Perkins KA (2009) Endophenotypes for nicotine dependence risk at or before initial nicotine exposure. In: Swan G (ed) Phenotypes and endophenotypes: foundations for genetic studies of nicotine use and dependence. NCI Monograph 22. National Cancer Institute, Rockville, MAGoogle Scholar
  3. Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A (2004) The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C] raclopride. Synapse 54:65–71PubMedCrossRefGoogle Scholar
  4. Benowitz NL, Henningfield JE (1994) Establishing a nicotine threshold for addiction. New Engl J Med 331:123–125PubMedCrossRefGoogle Scholar
  5. Benowitz NL, Jacob P, Fong I, Gupta S (1994) Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exper Ther 268:296–303Google Scholar
  6. Benowitz NL, Zevin S, Jacob P III (1997) Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Br J Clin Pharmacol 43:259–267PubMedCrossRefGoogle Scholar
  7. Bickel WK, Oliveto AH, Kamien JB, Higgins ST, Hughes JR (1993) A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans. J Pharmacol Exper Ther 264:360–367Google Scholar
  8. Blendy JA, Strasser A, Walters CL, Perkins KA, Patterson F, Berkowitz R, Lerman C (2005) Reduced nicotine reward in obesity: cross comparison in human and mouse. Psychopharmacology 180:306–315PubMedCrossRefGoogle Scholar
  9. Byrd GD, Davis RA, Caldwell WS, Robinson JH, deBethizy JD (1998) A further study of FTC yield and nicotine absorption in smokers. Psychopharmacology 139:291–299PubMedCrossRefGoogle Scholar
  10. Chaudhri N, Caggiula AR, Donny EC, Palmatier MI, Liu X, Sved AF (2006) Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology 184:353–366PubMedCrossRefGoogle Scholar
  11. Cone EJ (1995) Pharmacokinetics and pharmacodynamics of cocaine. J Analy Toxicol 19:459–478Google Scholar
  12. Desai RI, Terry P (2003) Evidence of cross-tolerance between behavioural effects of nicotine and cocaine in mice. Psychopharmacology 166:111–119PubMedGoogle Scholar
  13. Desai RI, Barber DJ, Terry P (1999) Asymmetric generalization between the discriminative stimulus effects of nicotine and cocaine. Behav Pharmacol 10:647–656PubMedCrossRefGoogle Scholar
  14. deWit H (1991) Preference procedures for testing the abuse liability of drugs in humans. Br J Addict 86:1579–1586CrossRefGoogle Scholar
  15. Duka T, Tasker R, Russell K, Stephens DN (1998) Discriminative stimulus properties of nicotine at low doses: the effects of caffeine preload. Behav Pharmacol 9:219–229PubMedCrossRefGoogle Scholar
  16. Duka T, Seiss E, Tasker R (2002) The effects of extrinsic context on nicotine discrimination. Behav Pharmacol 13:39–47PubMedGoogle Scholar
  17. Eissenberg T, Balster RL (2000) Initial tobacco use episodes in children and adolescents: current knowledge, future directions. Drug Alcohol Depend 59(Suppl 1):S41–S60PubMedCrossRefGoogle Scholar
  18. Fant RV, Schuh KJ, Stitzer ML (1995) Response to smoking as a function of prior smoking amounts. Psychopharmacology 119:385–390PubMedCrossRefGoogle Scholar
  19. Fischman MW, Foltin RW (1991) Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86:1563–1570PubMedCrossRefGoogle Scholar
  20. Gasior M, Jaszyna M, Munzar P, Witkin JM, Goldberg SR (2002) Caffeine potentiates the discriminative stimulus effects of nicotine in rats. Psychopharmacology 162:385–395PubMedCrossRefGoogle Scholar
  21. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR (2006) Varenicline, an a4b2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation. JAMA 296:47–55PubMedCrossRefGoogle Scholar
  22. Gourlay SG, Benowitz NL (1997) Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clin Pharmacol Ther 62:453–463PubMedCrossRefGoogle Scholar
  23. Henningfield JE, Keenan R (1993) Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol 61:743–750PubMedCrossRefGoogle Scholar
  24. Holtzman SG (1990) Discriminative stimulus effects of drugs: Relationship to potential for abuse. In: Modern methods in pharmacology, vol 6. Wiley, New York, pp 193–210Google Scholar
  25. Jarbe TUC, Laaksonen T, Svensson R (1983) Influence of exteroceptive contextual conditions upon internal drug stimulus control. Psychopharmacology 80:31–34PubMedCrossRefGoogle Scholar
  26. Johanson CE (1991) Discriminative stimulus effects of psychomotor stimulants and benzodi-azepines in humans. In: Glennon RA et al (eds) Drug discrimination: applications to drug abuse research. NIDA Research Monograph 116. U.S. Department of Health and Human Services, Washington, DC, pp 181–196Google Scholar
  27. Jones HE, Garrett BE, Griffiths RR (1999) Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers. J Pharmacol Exp Ther 288:188–197PubMedGoogle Scholar
  28. Kallman WM, Kallman MJ, Harry GJ, Woodson PP, Rosecrans JA (1982) Nicotine as a discriminative stimulus in human subjects. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier Biomedical, Amsterdam, pp 211–218Google Scholar
  29. Kalman D (2002) The subjective effects of nicotine: methodological issues, a review of experimental studies, and recommendations for future research. Nic Tob Res 4:25–70CrossRefGoogle Scholar
  30. Kalman D, Smith SS (2005) Does nicotine do what we think it does? A meta-analytic review of the subjective effects of nicotine in nasal spray and intravenous studies with smokers and nonsmokers. Nic Tob Res 7:317–333CrossRefGoogle Scholar
  31. Kamien JB, Bickel WK, Hughes JR, Higgins ST, Smith B (1993) Drug discrimination by humans compared to nonhumans: Current status and future directions. Psychopharmacology 111: 259–270PubMedCrossRefGoogle Scholar
  32. Kozlowski LT, Wilkinson DA, Skinner W, Kent C, Franklin T, Pope MA (1989) Comparing tobacco cigarette dependence with other drug dependencies. JAMA 261:898–901PubMedCrossRefGoogle Scholar
  33. Lamb RJ, Preston KL, Schindler CW, Meisch RA, Davis F, Katz JL, Henningfield JE, Goldberg SR (1991) The reinforcing and subjective effects of morphine in post-addicts: a dose-response study. J Pharmacol Exp Ther 259:1165–1173PubMedGoogle Scholar
  34. LeFoll B, Goldberg SR (2004) Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport 15:2139–2143CrossRefGoogle Scholar
  35. LeFoll B, Goldberg SR (2005) Ethanol does not affect discriminative stimulus effects of nicotine in rats. Eur J Pharmacol 519:96–102CrossRefGoogle Scholar
  36. Lerman C, Perkins KA, Gould T (2009) Nicotine dependence endophenotypes in chronic smokers. In: Swan G (ed) Phenotypes, endophenotypes, and genetic studies of nicotine dependence. National Cancer Institute Monograph 22. U.S. Public Health Service, Washington DCGoogle Scholar
  37. Madden PAF, Heath AC, Starmer GA, Whitfield JB, Martin NG (1995) Alcohol sensitivity and smoking history in men and women. Alcohol: Clin Exp Res 19:1111–1120CrossRefGoogle Scholar
  38. Malin DH, Alvarado CL, Woodhouse KS, Karp H, Urdiales E, Lay D, et al (2002) Passive immunization against nicotine attenuates nicotine discrimination. Life Sci 70:2793–2798PubMedCrossRefGoogle Scholar
  39. Mitchell SH, deWit H, Zacny JP (1995) Effects of varying ethanol dose on cigarette consumption in healthy normal volunteers. Behav Pharmacol 6:359–365PubMedGoogle Scholar
  40. Mumford GK, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR (1994) Discriminative stimulus and subjective effects of theobromine and caffeine in humans. Psychopharmacology 115:1–8PubMedCrossRefGoogle Scholar
  41. Mitchell SH, deWit H, Zacny JP (1995) Effects of varying ethanol dose on cigarette consumption in healthy normal volunteers. Behav Pharmacol 6:359–365PubMedGoogle Scholar
  42. Nemeth-Coslett R, Henningfield JE, O'Keefe MK, Griffiths RR (1986) Effects of mecamylamine on human cigarette smoking and subjective ratings. Psychopharmacology 88:420–425PubMedCrossRefGoogle Scholar
  43. Overton DA (1991) A historical perspective on drug discrimination. In: Glennon RA, Jarbe TUC, Frankenheim J (eds) Drug discrimination: applications to drug abuse research. NIDA Research Monograph 116. U.S. Department of Health and Human Services, Washington DC, pp 5–24Google Scholar
  44. Patton GC, Coffey C, Carlin JB, Sawyer SM, Lynskey M (2005) Reverse gateways? Frequent cannabis use as a predictor or tobacco initiation and nicotine dependence. Addiction 100: 1518–1525PubMedCrossRefGoogle Scholar
  45. Perkins KA (1999a) Baseline-dependency of nicotine effects: a review. Behav Pharmacol 10: 597–615CrossRefGoogle Scholar
  46. Perkins KA (1999b) Nicotine discrimination in men and women. Pharmacol Biochem Behav 64:295–299CrossRefGoogle Scholar
  47. Perkins KA (2002) Chronic tolerance to nicotine in humans and its relationship to tobacco dependence. Nic Tob Res 4:405–422CrossRefGoogle Scholar
  48. Perkins KA (2008) Sex differences in nicotine reinforcement and reward: influences on the persistence of tobacco smoking. In: Bevins R, Caggiula AR (eds) The motivational impact of nicotine and its role in tobacco use. Springer, New YorkGoogle Scholar
  49. Perkins KA, Scott JA (2008). Sex differences in long-term smoking cessation rates due to nicotine patch. Nic Tob Res 10(7):1245–1250CrossRefGoogle Scholar
  50. Perkins KA, Epstein LH, Stiller R, Jennings JR, Christiansen C, McCarthy T (1986) An aerosol spray alternative to cigarette smoking in the study of the behavioral and physiological effects of nicotine. Behav Res Meth Instr Comput 18:420–426Google Scholar
  51. Perkins KA, DiMarco A, Grobe JE, Scierka A, Stiller RL (1994a) Nicotine discrimination in male and female smokers. Psychopharmacology 116:407–413CrossRefGoogle Scholar
  52. Perkins KA, Sexton JE, Reynolds WA, Grobe JE, Fonte C, Stiller RL (1994b) Comparison of acute subjective and heart rate effects of nicotine intake via tobacco smoking vs. nasal spray. Pharmacol Biochem Behav 47:295–299CrossRefGoogle Scholar
  53. Perkins KA, Sexton JE, Stiller RL, Fonte C, DiMarco A, Goettler J, Scierka A (1994c) Subjective and cardiovascular responses to nicotine combined with caffeine during rest and casual activity. Psychopharmacology 113:438–444CrossRefGoogle Scholar
  54. Perkins KA, Grobe JE, Mitchell SL, Goettler J, Caggiula AR, Stiller RL, Scierka A (1995) Acute tolerance to nicotine in smokers: lack of dissipation within two hours. Psychopharmacology 118:164–170PubMedCrossRefGoogle Scholar
  55. Perkins KA, D'Amico D, Sanders M, Grobe JE, Scierka A, Stiller RL (1996a) Influence of training dose on nicotine discrimination in humans. Psychopharmacology 126:132–139CrossRefGoogle Scholar
  56. Perkins KA, Grobe JE, Weiss D, Fonte C, Caggiula A (1996b) Nicotine preference in smokers as a function of smoking abstinence. Pharmacol Biochem Behav 55:257–263CrossRefGoogle Scholar
  57. Perkins KA, Sanders M, D'Amico D, Wilson A (1997) Nicotine discrimination and self-administration as a function of smoking status. Psychopharmacology 131:361–370PubMedCrossRefGoogle Scholar
  58. Perkins KA, Donny E, Caggiula AR (1999a) Sex differences in nicotine effects and self-administration: human and animal evidence. Nic Tob Res 1:301–305CrossRefGoogle Scholar
  59. Perkins KA, Fonte C, Sanders M, White W, Wilson AS (1999b) Effects of training dose and two-versus three-choice testing procedure on nicotine discrimination responding in humans. Psy-chopharmacology 145:418–425Google Scholar
  60. Perkins KA, Sanders M, Fonte C, Wilson AS, White W, Stiller R, McNamara D (1999c) Effects of central and peripheral nicotinic blockade on human nicotine discrimination. Psychopharma-cology 142:158–164CrossRefGoogle Scholar
  61. Perkins KA, Gerlach D, Broge M, Grobe JE, Wilson A (2000) Greater sensitivity to subjective effects of nicotine in nonsmokers high in sensation-seeking. Exp Clin Psychopharmacol 8: 462–471PubMedCrossRefGoogle Scholar
  62. Perkins KA, Fonte C, Ashcom J, Broge M, Wilson A (2001a) Subjective responses to nicotine in smokers may be associated with responses to caffeine and to alcohol. Exp Clin Psychopharma-col 9:91–100CrossRefGoogle Scholar
  63. Perkins KA, Fonte C, Meeker J, White W, Wilson A (2001b) The discriminative stimulus and reinforcing effects of nicotine in humans following nicotine pre-treatment. Behav Pharmacol 12:35–44Google Scholar
  64. Perkins KA, Fonte C, Sanders M, Meeker J, Wilson A (2001c) Threshold doses for nicotine discrimination in smokers and nonsmokers. Psychopharmacology 155:163–170CrossRefGoogle Scholar
  65. Perkins KA, Gerlach D, Broge M, Fonte C, Wilson A (2001d) Reinforcing effects of nicotine as a function of smoking status. Exp Clin Psychopharmacol 9:243–250CrossRefGoogle Scholar
  66. Perkins KA, Gerlach D, Broge M, Grobe JE, Sanders M, Fonte C, Vender J, Cherry C, Wilson A (2001e) Dissociation of nicotine tolerance from tobacco dependence. J Pharmacol Exper Ther 296:849–856Google Scholar
  67. Perkins KA, Gerlach D, Vender J, Grobe JE, Meeker J, Hutchison S (2001f) Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. Nic Tob Res 3:141–150CrossRefGoogle Scholar
  68. Perkins KA, Broge M, Gerlach D, Sanders M, Grobe JE, Cherry C, Wilson AS (2002) Acute nicotine reinforcement, but not chronic tolerance, predicts withdrawal and relapse after quitting smoking. Health Psychol 2:332–339CrossRefGoogle Scholar
  69. Perkins KA, Sayette M, Conklin CA, Caggiula AR (2003) Placebo effects of tobacco smoking and other nicotine intake. Nic Tob Res 5:695–709CrossRefGoogle Scholar
  70. Perkins KA, Fonte C, Blakesley-Ball R, Stolinski A, Wilson AS (2005a) The influence of alcohol pre-treatment on the discriminative stimulus, subjective, and relative reinforcing effects of nicotine. Behav Pharmacol 16:521–529CrossRefGoogle Scholar
  71. Perkins KA, Fonte C, Blakesley-Ball R, Wilson AS (2005b) The discriminative stimulus, subjective, cardiovascular, and reinforcing effects of nicotine as a function of light physical activity. Nic Tob Res 7:591–600CrossRefGoogle Scholar
  72. Perkins KA, Fonte C, Stolinski A, Blakesley-Ball R, Wilson AS (2005c) The influence of caffeine on nicotine's discriminative stimulus, subjective, and reinforcing effects. Exper Clin Psy-chopharmacol 13:275–281CrossRefGoogle Scholar
  73. Perkins KA, Stitzer M, Lerman C (2006) Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology 184:628–636PubMedCrossRefGoogle Scholar
  74. Perkins KA, Conklin CA, Levine MD (2007) Cognitive-behavioral therapy for smoking cessation. Routledge, New YorkGoogle Scholar
  75. Perkins KA, Ciccocioppo M, Conklin C, Milanak M, Grottenthaler A, Sayette M (2008). Mood influences on acute smoking responses are independent of nicotine intake and dose expectancy. J Abn Psychol 117(1):79–93CrossRefGoogle Scholar
  76. Picciotto MR, Caldarone BJ, King SL, Zachariou V (2000) Nicotinic receptors in the brain: links between molecular biology and behavior. Neuropsychopharmacology 22:451–465PubMedCrossRefGoogle Scholar
  77. Pomerleau CS, Pomerleau OF, Majchrzak MJ (1987) Mecamylamine pre-treatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level. Psy-chopharmacology 91:391–393Google Scholar
  78. Pomerleau OF, Pomerleau CS, Rose JE (1989) Controlled dosing of nicotine: a review of problems and progress. Ann Behav Med 11:158–163CrossRefGoogle Scholar
  79. Preston KL (1991) Drug discrimination methods in human drug abuse liability evaluations. Br J Addict 86:1587–1594PubMedCrossRefGoogle Scholar
  80. Preston KL, Bigelow GE (1991) Subjective and discriminative effects of drugs. Behav Pharmacol 2:293–313PubMedCrossRefGoogle Scholar
  81. Preston KL, Bigelow GE (1998) Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose. Behav Pharmacol 9:533–543PubMedCrossRefGoogle Scholar
  82. Ray R, Jepson C, Patterson F, Strasser AA, Rukstalis M, Perkins KA, Lynch K, O'Malley S, Berrettini W, Lerman C (2006) Association of OPRM1 Asn40Asp variant with the relative reinforcing value of nicotine in female smokers. Psychopharmacology 188:355–363PubMedCrossRefGoogle Scholar
  83. Roberts TA, Pennebaker JW (1995) Gender differences in perceiving internal states: toward a his-and-hers model of perceptual cues. Adv Exp Soc Psychol 27:143–175CrossRefGoogle Scholar
  84. Rose JE (1984) Discriminability of nicotine in tobacco smoke: implications for titration. Addict Behav 9:189–193PubMedCrossRefGoogle Scholar
  85. Rose JE (2006) Nicotine and non-nicotine factors in cigarette addiction. Psychopharmacology 184:274–285PubMedCrossRefGoogle Scholar
  86. Rose JE, Corrigall WA (1997) Nicotine self-administration in animals and humans: similarities and differences. Psychopharmacology 130:28–44PubMedCrossRefGoogle Scholar
  87. Rose JE, Sampson A, Levin ED, Henningfield JE (1989) Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol Biochem Behav 32:933–938PubMedCrossRefGoogle Scholar
  88. Rose JE, Westman E, Behm F (1996) Nicotine-mecamylamine combination treatment for smoking cessation. Drug Dev Res 38:243–256CrossRefGoogle Scholar
  89. Rose JE, Westman E, Behm F, Johnson MP, Goldberg JS (1999) Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan. Pharmacol Biochem Behav 62:165–172PubMedCrossRefGoogle Scholar
  90. Rush CR, Critchfield TS, Troisi JR, Griffiths RR (1995) Discriminative stimulus effects of di-azepam and buspirone in normal volunteers. J Exper Anal Behav 63:277–294CrossRefGoogle Scholar
  91. Rush CR, Higgins ST, Vansickel AR, Stoops WW, Lile JA, Glaser PEA (2005) Methylphenidate increases cigarette smoking. Psychopharmacology 181:781–789PubMedCrossRefGoogle Scholar
  92. Russell MAH (1979) Tobacco dependence: is nicotine rewarding or aversive? In: Krasnegor NA (ed) Cigarette smoking as a dependence process. NIDA Research Monograph 23, U.S. Department of Health and Human Services, Washington DC, pp 100–122Google Scholar
  93. Schneider NG, Lunell E, Olmstead RE, Fagerstrom K-O (1996) Clinical pharmacokinetics of nasal nicotine delivery - A review and comparison to other nicotine systems. Clin Pharmacokinet 31:65–80PubMedCrossRefGoogle Scholar
  94. Shiffman S, Zettler-Segal M, Kassel J, Paty J, Benowitz NL, O'Brien G (1992) Nicotine elimination and tolerance in non-dependent cigarette smokers. Psychopharmacology 109:449–456PubMedCrossRefGoogle Scholar
  95. Singha AK, McCance-Katz EF, Heck SA, Kosten TR, Oliveto A (1999) Individual differences in humans responding under a cocaine discrimination procedure: discriminators versus nondis-criminators. Exper Clin Psychopharmacol 7:391–398CrossRefGoogle Scholar
  96. Smith BJ, Bickel WK (1999) The novel-response procedure in humans. Pharmacol Biochem Behav 64:245–250PubMedCrossRefGoogle Scholar
  97. Stolerman IP (1999) Inter-species consistency in the behavioural pharmacology of nicotine dependence. Behav Pharmacol 10:559–580PubMedCrossRefGoogle Scholar
  98. Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychopharmacology 117:2–10PubMedCrossRefGoogle Scholar
  99. Stolerman IP, Goldfarb T, Fink R, Jarvik ME (1973) Influencing cigarette smoking with nicotine antagonists. Psychopharmacology 28:217–259Google Scholar
  100. Stolerman IP, Garcha HS, Pratt JA, Kumar R (1984) Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology 84:413–419PubMedCrossRefGoogle Scholar
  101. Stolerman IP, Samele C, Kamien JB, Mariathasan EA, Hague DS (1995) Bibliography of drug discrimination research, 1992–1994. Behav Pharmacol 6:643–668PubMedCrossRefGoogle Scholar
  102. U.S. Department of Health and Human Services (USDHHS) (1988) The health consequences of smoking: nicotine addiction. A report of the U S surgeon general. U.S. Public Health Service, Washington DCGoogle Scholar
  103. van Hest A, Steckler T (1996) Effects of procedural parameters on response accuracy: lessons from delayed (non-) matching procedures in animals. Cog Brain Res 3:193–203CrossRefGoogle Scholar
  104. Young R, Glennon RA (2002) Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol 443:113–118PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Kenneth A. Perkins
    • 1
  1. 1.Western Psychiatric Institute and ClinicUniversity of Pittsburgh School of MedicinePittsburghUSA

Personalised recommendations